CTLA4 and neoplasm: To test whether PD-L1 is induced at the tissue level in response to anti–CTLA-4 therapy, we performed immunofluorescence staining of PD-L1 and CD3 in the liver and kidney of tumor-bearing mice treated with 9D9 alone or in combination with other therapies (Figure 7A).